Acacia Pharma Group plc: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2021)
- $1.2M
- Net Income/Loss (FY2021)
- -$67.1M
- Total Assets (FY2021)
- $62.0M
- Total Equity (FY2021)
- $25.9M
- Cash Flows from Operating Activities (FY2021)
- -$44.6M
Source: Acacia Pharma Group plc annual_report filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
